Despite dire predictions that the Zika virus could affect much of the United States including large cities this summer, two public health law experts warn that the country is unprepared, and the financial and moral consequences could be significant.
For the first time, the Inter-American Commission on Human Rights takes up tobacco use as a human rights issue during a hearing on Tuesday, April 5, 2016.
Policy, advocacy and infectious disease experts will discuss the Zika virus crisis and potential U. S. policy implications on Tuesday, March 15; 9 to 10:30 am on Capitol Hill.
Georgetown public health law expert Lawrence O. Gostin, J.D., will address U.S. domestic preparedness for the fast-spreading Zika virus during testimony, given at the invitation of the U.S. House Energy and Commerce Subcommittee on Oversight and Investigations on Wednesday, March 2nd at 10:15 a.m.
Georgetown infectious disease expert Daniel Lucey, MD, MPH, will deliver a presentation titled “WHO Reforms and UN Action” during the “Ebola and Beyond: Preparing for the Next Pandemic” symposium at the 17th International Congress on Infectious Diseases (ICID), March 2-5, 2016 in Hyderabad, India.
The World Health Organization posted its “ZIKA Strategic Response Framework & Joint Operations Plan” on Feb. 16. Global health law expert Lawrence O. Gostin, JD, faculty director of the O’Neill Institute for National and Global Health Law at Georgetown University, is pleased to see the WHO plan but says the financing needed to stem the Zika epidemic is grossly underestimated.
There is a significant correlation between the Hepatitis C and opioid abuse epidemics that has been overlooked in the FY 2017 budget proposals, and indicates a missed opportunity by the government to concurrently provide funding to address both of these public health concerns.
In this opinion piece, Sean Bland, JD, an associate at the O’Neill Institute for National and Global Health Law at Georgetown University, discusses President Obama’s proposed pilot program to increase access to pre-exposure prophylaxis for HIV prevention.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right